Screening programme approach | Referral criteria | Proportion (%) referred for treatment | Proportion (%) LTBI* cases detected (detection rate) | Proportion (%) non-infected referred for treatment (false positive rate) |
---|---|---|---|---|
Only TST | TST ≥ 6 mm | 50 | 89 | 42 |
TST ≥ 10 mm | 34 | 75 | 27 | |
TST ≥ 15 mm | 15 | 47 | 0 | |
Only QFT | QFT positive | 29 | 88 | 0 |
Two step (first TST, then QFT) | TST ≥ 6 mm and QFT positive, or TST ≥15 mm | 29 | 89 | 0 |
TST ≥ 10 mm and QFT positive or TST ≥ 15 mm | 25 | 75 | 0 | |
TST ≥ 15 mm (with or without QFT positives afterwards) | 15 | 47 | 0 |